IP Verse

Nutraceutical Or Pharmaceutical Composition For Use In The Treatment Of Polycystic Ovary Syndrome Or Of Diseases Or Disorders Related Thereto

Patent No. EP3452012 (titled "Nutraceutical Or Pharmaceutical Composition For Use In The Treatment Of Polycystic Ovary Syndrome Or Of Diseases Or Disorders Related Thereto") was filed by S&R Farmaceutici on Apr 13, 2017. The application was issued on Jun 23, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LOLI PHARMAMar 22, 2022PACE NAPOLEONE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3452012

S&R FARMACEUTICI
Application Number
EP17727376A
Filing Date
Apr 13, 2017
Status
Opposition Rejected
Feb 9, 2024
Publication Date
Jun 23, 2021
External Links
Slate, Register , Google Patents